Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Privi Speciality Che
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Privi Speciality Che

WEBSITE BSE:530117 NSE: PRIVISCL Inc. Year: 1985 Industry: Chemicals My Bucket: Add Stock

₹3133.1 191.4 | 6.5%

Last updated: 15:57

Consolidated Standalone

Last updated: 15:57

Privi Speciality Che Overview

Privi Speciality Chemicals Ltd, formerly known as Fairchem Speciality Ltd, is an totally India-based agency engaged within the business of producing of speciality chemicals. The Company manufactures oleo chemicals, aroma chemical substances and intermediate neutraceuticals. The Company manufactures products, such as linoleic acid, dimer acid and monomer acid, herbal blended tocopherol concentrate and concentrated sterols. The Company's oleo chemicals are utilized in diverse industries, which includes paints, inks, soaps, amines and adhesives. I...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Privi Speciality Che Key Financials

Market Cap ₹12239 Cr.

Stock P/E 66.2

P/B 9.3

Current Price ₹3133.1

Book Value ₹ 336.6

Face Value 10

52W High ₹3433

Dividend Yield 0.16%

52W Low ₹ 1837.1

Edit Ratio

Privi Speciality Che Share Price

₹ | |

Volume
Price

Privi Speciality Che Quarterly Price

Quarterly Monthly
Show Value Show %

Privi Speciality Che Peer Comparison

Privi Speciality Che Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 455 404 484 464 533 491 614 559 679 605
Other Income 7 6 8 3 4 2 15 9 0 7
Total Income 462 409 492 467 537 493 628 568 679 611
Total Expenditure 366 314 393 370 423 378 481 427 497 453
Operating Profit 96 96 99 97 115 115 147 141 182 158
Interest 25 24 25 22 22 22 23 24 21 19
Depreciation 31 32 30 32 32 32 35 36 36 36
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 40 39 44 43 61 61 90 81 125 104
Provision for Tax 10 10 12 11 16 16 26 24 35 29
Profit After Tax 30 29 32 31 45 44 64 58 90 75
Adjustments 0 -0 -1 -0 -0 -0 3 4 4 3
Profit After Adjustments 31 29 31 31 45 44 67 62 94 78
Adjusted Earnings Per Share 7.8 7.4 7.9 8 11.4 11.4 17 15.9 24 20

Privi Speciality Che Profit & Loss

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 597 1024 1341 1324 1277 1404 1608 1752 2101 2457
Other Income 10 16 6 26 20 32 21 26 21 31
Total Income 608 1040 1347 1350 1297 1436 1629 1779 2122 2486
Total Expenditure 525 894 1128 1104 1067 1209 1420 1424 1643 1858
Operating Profit 82 146 218 247 230 227 209 355 479 628
Interest 20 24 29 38 24 25 70 102 92 87
Depreciation 27 43 47 57 71 75 108 123 132 143
Exceptional Income / Expenses 0 0 9 40 23 5 0 0 0 0
Profit Before Tax 36 79 152 193 158 133 31 130 255 400
Provision for Tax 8 26 57 47 41 35 10 34 70 114
Profit After Tax 27 53 94 146 117 97 21 95 185 287
Adjustments 0 0 0 0 0 0 1 -1 2 14
Profit After Adjustments 27 53 94 146 117 97 22 95 187 301
Adjusted Earnings Per Share 7.2 14.2 24.1 37.4 29.9 24.9 5.7 24.3 47.9 76.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 20% 14% 10% 0%
Operating Profit CAGR 35% 28% 14% 0%
PAT CAGR 95% 24% 5% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 70% 42% 28% 26%
ROE Average 18% 11% 12% 14%
ROCE Average 17% 12% 12% 13%

Privi Speciality Che Balance Sheet

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 444 488 576 612 723 812 829 924 1103
Minority's Interest 0 0 0 0 0 7 6 17 14
Borrowings 66 77 181 226 332 381 404 445 511
Other Non-Current Liabilities 25 31 39 33 32 47 51 61 58
Total Current Liabilities 403 457 630 513 454 929 1101 896 1103
Total Liabilities 939 1053 1426 1384 1540 2176 2391 2343 2791
Fixed Assets 388 435 498 598 598 704 1017 1034 1156
Other Non-Current Assets 67 77 127 58 242 419 172 166 271
Total Current Assets 485 541 801 728 700 1053 1202 1142 1363
Total Assets 939 1053 1426 1384 1540 2176 2391 2343 2791

Privi Speciality Che Cash Flow

#(Fig in Cr.) Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 12 16 85 15 33 20 24
Cash Flow from Operating Activities 17 107 21 216 149 5 49 354 281
Cash Flow from Investing Activities -67 -81 -139 -176 -242 -320 -133 -180 -294
Cash Flow from Financing Activities -89 -20 122 28 23 333 72 -171 39
Net Cash Inflow / Outflow -140 5 4 68 -69 17 -12 4 26
Closing Cash & Cash Equivalent 7 12 16 85 15 33 20 24 50

Privi Speciality Che Ratios

# Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 7.21 14.19 24.13 37.38 29.93 24.93 5.69 24.3 47.87
CEPS(Rs) 14.34 25.7 36.12 51.92 48.1 44.04 33.22 56.02 81.02
DPS(Rs) 1 1.5 2.5 1.5 2 2 0 2 5
Book NAV/Share(Rs) 117.7 129.47 147.37 156.68 184.96 207.8 212.24 236.64 282.48
Core EBITDA Margin(%) 11.31 12.48 15.68 16.63 16.42 13.88 11.67 18.75 21.8
EBIT Margin(%) 8.72 9.86 13.31 17.36 14.23 11.25 6.26 13.21 16.51
Pre Tax Margin(%) 5.59 7.57 11.17 14.52 12.38 9.45 1.93 7.41 12.11
PAT Margin (%) 4.26 5.11 6.95 11.01 9.15 6.93 1.32 5.45 8.79
Cash Profit Margin (%) 8.48 9.26 10.4 15.29 14.7 12.25 8.07 12.49 15.06
ROA(%) 2.89 5.36 7.6 10.4 8 5.24 0.93 4.03 7.2
ROE(%) 6.13 11.48 17.74 24.59 17.52 12.69 2.59 10.88 18.22
ROCE(%) 7.25 13 19.17 21.11 15.36 10.64 5.58 12.22 16.88
Receivable days 99.76 70.7 75.49 77.01 66.81 65.48 63.62 66.98 64.42
Inventory Days 141.22 83.95 80.47 95.36 95.83 124.57 160.66 151.93 125.75
Payable days 115.18 76.27 81.89 84.18 78.85 107.03 116.54 93.78 78.7
PER(x) 75.96 26.57 19.21 11.17 28.34 75.35 184.75 40.78 35.66
Price/Book(x) 4.65 2.91 3.14 2.66 4.58 9.04 4.95 4.19 6.04
Dividend Yield(%) 0.18 0.4 0.54 0.36 0.24 0.11 0 0.2 0.29
EV/Net Sales(x) 3.94 1.68 1.7 1.54 3 5.85 3.19 2.75 3.68
EV/Core EBITDA(x) 28.57 11.8 10.43 8.28 16.64 36.09 24.56 13.58 16.14
Net Sales Growth(%) 0 71.49 30.92 -1.26 -3.59 9.96 14.54 8.98 19.91
EBIT Growth(%) 0 85.41 75.49 27.48 -20.98 -13.11 -36.35 130.04 49.9
PAT Growth(%) 0 96.69 76.65 54.95 -19.95 -16.7 -78.15 348.49 93.6
EPS Growth(%) 0 96.69 70.08 54.95 -19.95 -16.7 -77.19 327.22 97.03
Debt/Equity(x) 0.72 0.67 0.85 0.82 0.73 1.12 1.27 1.06 1
Current Ratio(x) 1.2 1.18 1.27 1.42 1.54 1.13 1.09 1.27 1.24
Quick Ratio(x) 0.59 0.67 0.69 0.78 0.79 0.47 0.37 0.54 0.52
Interest Cover(x) 2.78 4.3 6.22 6.13 7.68 6.25 1.45 2.28 3.76
Total Debt/Mcap(x) 0.16 0.23 0.27 0.31 0.16 0.12 0.26 0.25 0.17

Privi Speciality Che Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 74.05 74.05 74.05 74.05 74.05 74.05 69.89 69.89 60.6 60.6
FII 0.96 0.62 0.48 0.43 0.48 0.4 1.47 1.33 1.64 1.38
DII 3.4 3.37 2.84 2.5 2.09 1.95 3.9 4.55 10.24 10.67
Public 21.6 21.95 22.63 23.03 23.38 23.61 24.74 24.23 27.52 27.36
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Privi Speciality Che News

Privi Speciality Che Pros & Cons

Pros

  • Debtor days have improved from 93.78 to 78.7days.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
  • Stock is trading at 9.3 times its book value.
  • The company has delivered a poor profit growth of 4% over past five years.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!